期刊文献+

siRNA干扰骨形态发生蛋白2对肝癌SMMC7721细胞迁移和侵袭能力的抑制作用 被引量:1

siRNA-BMP-2 inhibits migration and invasion of human hepatoma cell line SMMC7721
下载PDF
导出
摘要 目的设计并化学合成针对骨形态发生蛋白2(bone morphogenetic proteins,BMP-2)的siRNA分子片段,转染人肝癌SMMC7721细胞,观察其对SMMC7721细胞迁移和侵袭能力的影响。方法设计并化学合成针对BMP-2的3个siRNA分子序列,阳离子脂质体法瞬间转染SMMC7721细胞,运用半定量逆转录聚合酶链反应(RT-PCR)和Western印迹法检测细胞中BMP-2在mRNA水平和蛋白水平的变化,体外侵袭实验检测转染后细胞侵袭能力的变化。实验共分6组,①正常对照组;②空白对照组;③阴性对照组;④~⑥分别为BMP-2-siRNA-A、BMP-2-siRNA-B、BMP-2-siRNA-C转染组。结果RT-PCR和Western blot显示3对特异性BMP-2-siRNA转染肝癌细胞SMMC7721之后,其BMP-2的基因和蛋白表达均受到抑制,以siRNA-B抑制效果最明显[(0.32±0.07)vs(0.92±0.14),(0.37±0.10)vs(0.89±0.17),P<0.01]。体外侵袭实验显示转染后肝癌细胞数明显低于未转染组和阴性对照组[分别为(6.48±3.62)、(23.72±3.24)、(22.38±3.84),P<0.05]。结论BMP-2与肝癌的侵袭转移潜能相关,siRNA-BMP-2能明显抑制肝癌细胞SMMC7721的BMP-2表达,从而抑制肝癌细胞的迁移和侵袭能力。 Objective To design and prepare siRNAs targeting bone morphogenetic protein 2 (BMP-2) gene and to observe its effect on the migration and invasion of SMMC7721 cells. Methods Three specific siRNAs targeting BMP-2 were designed and synthesized, and then transiently transfected into SMMC7721 cells via cathodolyte fiposome transfeetion method. Reverse transcriptase PCR and Western blotting were used to detect BMP-2 expression at mRNA and protein levels. The migration and invasion ability of cancer cell were assessed by cell scratch assay and in vitro invasion assay respectively. There are 6 groups, Group Ⅰ : Normal control group ; Group Ⅱ : Control group ; Group Ⅲ : Negative control group ; Group Ⅳ, Ⅴ, Ⅵ : transfected with BMP-2-siRNA-A,BMP-2-siRNA-B, BMP-2-siRNA-C, respectively. Results After all the 3 specific BMP-2- siRNA (A, B, C) were transfected into SMMC7721 cells, the expression of BMP-2 mRNA and protein were significantly inhibited, with BMP-2-siRNA-B having the highest inhibitory rate [ (0.32 ± 0.07 ) vs (0.92 ±0. 14), (0.37 ±0.10) vs (0.89 ±0.17), P 〈0.01 ]. The invasion assay demonstrated that the number of hepatoma cancer cells in transfection group was significantly lower than that in untransfected group, blank con- trol group and negative control group [ ( 6.48 ± 3.62) vs (23.72 ± 3.24), (22.38 ± 3.84), P 〈 0. 05 ], which suggested that silencing BMP-2 gene obviously decreased the migration and invasion ability of hepatoma cancer ceils. Conclusion BMP-2 is correlated with the migration and invasion potential of hepatoma cells. The siRNA of BMP-2 gene effectively inhibits the mRNA and protein expression of BMP-2, and then restrain the migration and invasion ability of the cells.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2009年第23期2330-2333,共4页 Journal of Third Military Medical University
基金 江西省卫生厅资助基金(20081017)~~
关键词 肝肿瘤 骨形态发生蛋白 RNA干扰 迁移 侵袭 liver neoplasms bone morphogenetic proteins RNA interference migration invasion
  • 相关文献

参考文献11

  • 1Langenfeld E M, Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors [ J ]. Mol Cancer Res, 2004,2 (3) :141 - 149.
  • 2Davies S R, Watkins G, Douglas-Jones A, et al. Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/ prognostic relevance [ J]. J Exp Ther Oncol, 2008, 7 (4) : 327 - 338.
  • 3Langenfeld E M, Calvano S E, Abou-Nukta F, et al. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells[ J]. Carcinogenesis, 2003,24 (9) : 1445 - 1454.
  • 4Busch C, Drews U, Eisele S R, et al. Noggin blocks invasive growth of murine B16-F1 melanoma cells in the optic cup of the chick embryo [J]. Int J Cancer, 2008,122(3):526-533.
  • 5Rothhammer T, Poser I, Soncin F, et al. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration [ J ]. Cancer Res, 2005,65 ( 2 ) : 448 - 456.
  • 6Montesano R. Bone morphogenetic protein-4 abrogates lumen formation by mammary epithelial cells and promotes invasive growth [ J ]. Biochem Biophys Res Commun, 2007,353 ( 3 ) : 817 - 822.
  • 7Deng H, Makizumi R, Ravikumar T S, et al. Bone morphogenetic prorein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells [ J ]. Exp Cell Res, 2007,313 ( 5 ) : 1033 - 1044.
  • 8Langenfeld E M, Bojnowski J, Perone J, et al. Expression of bone morphogenetic proteins in human lung carcinomas [ J ]. Ann Thorac Surg,2005,80( 3 ) : 1028 - 1032.
  • 9Darby S, Cross S S, Brown N J, et al. BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype [ J]. J Pathol, 2008,214 (3) :394 - 404.
  • 10Piccirillo S G, Reynolds B A, Zanetti N, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells[J]. Nature, 2006, 444(7120) : 761 -765.

二级参考文献13

  • 1Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804.
  • 2Langenfeld EM, Bojnowski J, Perone J, Langenfeld J. Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg 2005; 80: 1028-1032.
  • 3Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 2003; 24: 1445-1454.
  • 4Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 2005; 65:448-456.
  • 5Beck SE, Jung BH, Fiorino A, Gomez J, Rosario ED, Cabrera BL, Huang SC, Chow JY, Carethers JM. Bone morphogenetic protein signaling and growth suppression in colon cancer. Am J PhysioI Gastrointest Liver Physiol 2006; 291:G135-G145.
  • 6Yang S, Pham LK, Liao CP, Frenkel B, Reddi AH, Roy-Burman P. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Res 2008; 68:198-205.
  • 7Sotobori T, Ueda T, Myoui A, Yoshioka K, Nakasaki M, Yoshikawa H, Itoh K. Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts. Exp Cell Res 2006; 312:3927-3938.
  • 8Bobinac D, Maric I, Zoricic S, Spanjol J, Dordevic G, Mustac E, Fuckar Z. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat Med J 2005; 46: 389-396.
  • 9Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism. Cancer Res 2005; 65:8274-8785.
  • 10Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M, Totonchy M, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008; 13:69-80.

共引文献5

同被引文献11

  • 1周玉,胡川闽.IRF-4结合蛋白——一个新的Th2极性分化相关分子[J].免疫学杂志,2006,22(5):580-583. 被引量:2
  • 2Gupta S, Lee A, Hu C, et al. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system [J]. Hum Immunol, 2003, 64(4): 389 -401.
  • 3Mavrakis K J, McKinlay K J, Jones P, et al. DEF6, a novel PH-DH- like domain protein, is an upstream activator of the Rho GTPases Racl, Cdc42, and RhoA [J]. Exp Cell Res, 2004, 294(2) : 335 - 344.
  • 4Vega F M, Ridley A J. Rho GTPases in cancer cell biology [ J]. FEBS Lett, 2008, 582 ( 14 ) : 2093 - 2101.
  • 5Zhang Z, Wang Q, Li P, et al. Overexpression of the Interferon regulatory factor 4-binding protein in human eoloreetal eancer and its clinical significance [J]. Cancer Epidemiol , 2009, 33(2) : 130 -136.
  • 6Li P, Zhang Z, Wang Q, et al. The ectopie expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells [ J ]. lnt Immunopharmacol, 2009, 9 (7/8) : 1002- 1009.
  • 7Merajver S D, Usmani S Z. Multifaceted role of Rho proteins in angiogenesis[ J]. J Mammary Gland Biol Neoplasia , 2005, 10 (4) : 291 - 298.
  • 8Maughan K L, Lutterbie M A, Ham P S. Treatment of breast cancer [J]. Am Fam Physician, 2010, 81(11): 1339-1346.
  • 9张竹君,周玉,李鹏,易维京,杨明珍,李淑慧,胡川闽.一个新的高保守自身免疫反应相关分子IRF-4结合蛋白多克隆抗体制备[J].第三军医大学学报,2008,30(13):1242-1245. 被引量:3
  • 10郑科,厉红元,苏新良,王小毅,谭金祥,孔令全,任国胜.CXCR7/CXCL12对人乳腺癌细胞侵袭和黏附能力的影响[J].第三军医大学学报,2010,32(1):63-66. 被引量:13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部